ARCHIVES

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

NCI director recognizes work of staff.

October 17, 2003

Organ Systems Program Progress, Momentum Threatened During transition, Karr Contends

December 9, 1988

Funding Opportunities

April 26, 2002

Carter Accepts Upton’s Resignation Effective Dec. 31; DeVita Acting Director; Search Committee Formed

December 7, 1979

Maguire Backs Cancer Program But Insists On New Emphasis for Prevention

January 26, 1979

Flood Says Congress Will Renew Cancer Act, But Only After “All Out” Review of Research Policy

December 3, 1976